The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
about
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-AnalysisTNFalpha: a trigger of autonomic dysfunctionThe prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.Adipose tissue pathways involved in weight loss of cancer cachexiaUnderstanding cancer-induced cachexia: imaging the flame and its fuel.Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexiaA difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care.Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the Yoshida sarcoma.Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma.Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growthDownregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles.A Preoperative Nutritional Index for Predicting Cancer-Specific and Overall Survival in Chinese Patients With Laryngeal Cancer: A Retrospective StudyThe Level of Serum Cholesterol is Negatively Associated with Lean Body Mass in Korean non-Diabetic Cancer Patients.Characterization of the Yoshida sarcoma: a model of cancer cachexia.TNF activates astrocytes and catecholaminergic neurons in the solitary nucleus: implications for autonomic controlImmunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.The study on mechanism of the modified Chinese herbal compound, jianpijiedu, on a mouse model of hepatic carcinoma cachexiaMyeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.An inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials.Inflammation as a validated prognostic determinant in carcinoma of unknown primary siteNonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.A literature review of end-stage renal disease and cachexia: understanding experience to inform evidence-based healthcare.Nutrition screening and counseling in patients with lung cancer in an outpatient setting.Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer.Differentiating Sarcopenia and Cachexia Among Patients With Cancer.Postoperative Prognostic Nutritional Index Predicts Survival of Patients with Hepatocellular Carcinoma within Milan Criteria and Hypersplenism.Increased number of volatile organic compounds over malignant glottic lesions.Serum metabolic profiles reveal the effect of formoterol on cachexia in tumor-bearing mice.Understanding tumor anabolism and patient catabolism in cancer-associated cachexiaNutrition Support for Critically Ill Patients With Cancer.Knockdown of metallothionein 1 and 2 does not affect atrophy or oxidant activity in a novel in vitro model.Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV.Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic.Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.Prognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma.Advanced non-small cell lung cancer associated with hemophagocytic syndrome in a cachectic patient.
P2860
Q26751553-B9986B8A-FF5D-48DB-B3E4-9B7281004D45Q33155571-93FC3879-79F8-4A0C-82E9-AC035048443BQ33588869-9D013793-3620-43AD-962C-9EE389066CF6Q33847854-47AD7C1F-0619-4985-B9A5-452E01D8E2F4Q34138093-4BA6FA3F-355F-42EF-BACC-C67CC07AA112Q34200939-82F4FB26-E4E1-4F9D-837F-CE17F0349F52Q34995229-3EB72850-2443-4FC9-BEA2-21979532F643Q35109504-9208F216-A564-48A9-AD11-12C3BA867E93Q35889913-B20C36EE-69E4-491A-8926-5CB1F1B415F9Q36069598-4E2B8BA1-BEAD-470F-8DB2-EEC1797FBAB1Q36287097-C84C6043-367B-41A9-A33A-4C9BBEC73D20Q36562311-1DA386E9-9482-4A57-9F1E-A01597F95477Q36608759-7820DFCB-E9F5-4795-A698-EC918B4E95B3Q36631208-13A30F8F-1A16-4436-9DC8-73F0BC0187DBQ36822645-32FEADD3-2EAE-4424-912E-FD3CB53321A5Q36864262-EBBF3DF2-1FCC-42CF-BE67-452DDF1F5D1BQ37190590-BCB8A1FF-1C0C-47F3-A5C3-584DEA6C07C7Q37219340-C5C7D0F1-2469-42A1-90EA-4A9DB33AE489Q37244823-31629700-1943-4074-80D8-7B47FFF405A0Q37297407-27E2A40B-5E40-4690-B79B-A5B8AA0EDD05Q37313761-2460F45C-F74A-4DF3-B123-4C716CE82B8BQ37444815-157916D5-0EB0-4DD0-9A03-443B4755AA91Q37459607-D8EF4D81-39E4-47BA-9CDC-A7876FA7696BQ37620387-31D73080-33CC-4654-A7A7-E9F6875D42A3Q37711669-10F2FBD2-3840-4D63-BE78-9D935CC4797FQ38083830-1F66909F-DF37-4FD5-A6CA-D4E87711C817Q38230415-616CC92F-0A1D-4B2E-BA22-BFED15F35F96Q38672357-625FE8E1-AF4A-4364-A592-5DF936673378Q38765640-B3CC520E-C1FB-4B60-9FE1-23AF4C735976Q38775584-396123B2-EB1F-404E-A153-B9F7B81666D9Q38951029-0C9ABB14-547C-45E7-9CB0-302E8BC21559Q39093151-439F3042-1D88-4AFD-95F1-A7049CD697D3Q39339489-C3497599-3B15-4CCD-A068-C789FCBC4967Q39386286-2386AF2D-53A6-40A2-B495-4A93267DD285Q39662824-2EE8EDB1-F181-409A-81C1-2E0E4BF88582Q40118082-FF87A0A8-C001-4B4C-B082-641235797091Q40771523-08C7D862-9160-45A4-BA79-F31E6531A5AFQ41174378-DDA6AA07-8EDC-44F9-9896-CC209B7AB9C2Q41555322-5AD8BD83-58DD-4CE6-8237-DEAFC14CD97DQ42102906-379D43EB-7968-48AF-9A0B-7B56DF924628
P2860
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@ast
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@en
type
label
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@ast
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@en
prefLabel
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@ast
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@en
P2860
P1476
The cancer cachexia syndrome: a review of metabolic and clinical manifestations.
@en
P2093
Dema Halasa Esper
Wael A Harb
P2860
P304
P356
10.1177/0115426505020004369
P577
2005-08-01T00:00:00Z